CD8A and neoplasm: CCR7 is mainly expressed on some subsets of CD8+ T lymphocytes, naïve T lymphocytes (CCR7+ CD45RA+) and central memory T lymphocytes (CCR7+ CD45RA−), which may differentiate into CTL to acquire an anti-tumor function [44].